文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症呼吸衰竭与机械通气

肾脏支持时机与脓毒性休克和急性呼吸窘迫综合征的结局:AKIKI随机临床试验的事后分析

Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01
一句话结论在严重急性肾损伤合并脓毒性休克或ARDS的患者中,早期启动肾脏替代治疗与延迟启动相比,60天死亡率无显著差异,延迟策略可使约45%患者避免RRT。

该研究为AKIKI随机临床试验的事后分析,纳入619例严重急性肾损伤患者,其中348例(56%)合并脓毒性休克,207例(33%)合并ARDS。按基线脓毒症状态、ARDS状态及严重程度评分分层,比较早期与延迟启动肾脏替代治疗对60天死亡率的影响。结果显示,基线脓毒症状态(P=0.28)、ARDS状态(P=0.94)及严重程度评分(SAPS 3 P=0.77,SOFA P=0.46)均未显著影响两种策略的60天死亡率比较。延迟策略使45%的脓毒性休克患者和46%的ARDS患者免于RRT,且延迟组尿量更高,脓毒性休克或ARDS患者的肾功能恢复更早(P<0.001和P=0.003),ARDS患者拔管成功时间不受RRT策略影响(P=0.43)。

要点

  • 在严重急性肾损伤合并脓毒性休克患者中,早期与延迟启动RRT的60天死亡率比较无显著差异(P=0.28)。
  • 在严重急性肾损伤合并ARDS患者中,早期与延迟启动RRT的60天死亡率比较无显著差异(P=0.94)。
  • 延迟RRT策略使45%的脓毒性休克患者和46%的ARDS患者避免接受RRT。
  • 延迟RRT策略组尿量更高,且脓毒性休克或ARDS患者的肾功能恢复更早(P<0.001和P=0.003)。
  • ARDS患者的拔管成功时间不受RRT启动策略影响(P=0.43)。

适用人群与场景

  • 严重急性肾损伤患者,来自AKIKI随机临床试验,其中基线合并脓毒性休克(Sepsis-3定义)者348例(56%),合并ARDS(柏林定义)者207例(33%)。
  • 亚组按基线脓毒症状态、ARDS状态、简化急性生理学评分3(SAPS 3)和脓毒症相关器官衰竭评估(SOFA)划分。

诊断标准与关键阈值

  • 脓毒症状态采用Sepsis-3定义。
  • ARDS状态采用柏林定义。

研究设计与关键结果

  • 研究类型:AKIKI随机临床试验的事后分析,样本量619例。
  • 基线脓毒症状态对早期与延迟RRT策略的60天死亡率比较无显著影响(P=0.28)。
  • 基线ARDS状态对两种策略的60天死亡率比较无显著影响(P=0.94)。
  • 基线SAPS 3(P=0.77)和SOFA(P=0.46)评分对两种策略的60天死亡率比较无显著影响。
  • 延迟RRT启动策略使45%的脓毒性休克患者和46%的ARDS患者免于RRT。
  • 延迟组尿量高于早期组。
  • 脓毒性休克或ARDS患者中,延迟RRT策略组肾功能恢复更早(P<0.001和P=0.003)。
  • ARDS患者拔管成功时间不受RRT策略影响(P=0.43)。

证据类型、等级与局限

  • 证据类型:随机临床试验(AKIKI)的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在严重急性肾损伤合并脓毒性休克或ARDS的脆弱人群中,早期RRT启动策略未显示60天死亡率改善,作者认为不必要的和潜在风险的操作可能经常可以避免。

指南或共识出处

  • AKIKI(Artificial Kidney Initiation in Kidney Injury)随机临床试验,临床试验注册号NCT 01932190。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: The optimal strategy for initiation of renal replacement therapy (RRT) in patients with severe acute kidney injury in the context of septic shock and acute respiratory distress syndrome (ARDS) is unknown.

OBJECTIVES: To examine the effect of an early compared with a delayed RRT initiation strategy on 60-day mortality according to baseline sepsis status, ARDS status, and severity.

METHODS: Post hoc analysis of the AKIKI (Artificial Kidney Initiation in Kidney Injury) trial.

MEASUREMENTS AND MAIN RESULTS: Subgroups were defined according to baseline characteristics: sepsis status (Sepsis-3 definition), ARDS status (Berlin definition), Simplified Acute Physiology Score 3 (SAPS 3), and Sepsis-related Organ Failure Assessment (SOFA). Of 619 patients, 348 (56%) had septic shock and 207 (33%) had ARDS. We found no significant influence of the baseline sepsis status (P = 0.28), baseline ARDS status (P = 0.94), and baseline severity scores (P = 0.77 and P = 0.46 for SAPS 3 and SOFA, respectively) on the comparison of 60-day mortality according to RRT initiation strategy. A delayed RRT initiation strategy allowed 45% of patients with septic shock and 46% of patients with ARDS to escape RRT. Urine output was higher in the delayed group. Renal function recovery occurred earlier with the delayed RRT strategy in patients with septic shock or ARDS (P < 0.001 and P = 0.003, respectively). Time to successful extubation in patients with ARDS was not affected by RRT strategy (P = 0.43).

CONCLUSIONS: Early RRT initiation strategy was not associated with any improvement of 60-day mortality in patients with severe acute kidney injury and septic shock or ARDS. Unnecessary and potentially risky procedures might often be avoided in these fragile populations. Clinical trial registered with www.clinicaltrials.gov (NCT 01932190).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Gaudry S, Hajage D, Schortgen F, et al. Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial. Am J Respir Crit Care Med. 2018. PMID: 29351007. doi:10.1164/rccm.201706-1255OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。